Abstract In a very double-blind, cross-about trial, triazolam (0.twenty five mg) was examined in opposition to flunitrazepam (one mg) in the typical midwinter sleeplessness and that is frequently observed among in any other case balanced persons in Northern Norway. Every drug was presented for 5 evenings, in random order, using a 5-night time place